ArticleIn vivo (Athens, Greece)

Long-term Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients With Relapsed/Refractory Multiple Myeloma.

Joon Young Hur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.